Targeting tumor‐associated macrophages: A potential treatment for solid tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting tumor‐associated macrophages: A potential treatment for solid tumors
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-11-17
DOI
10.1002/jcp.30139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
- (2020) Vildan B. Cetintas et al. Journal of Translational Medicine
- A ketogenic diet elicits anti-tumor properties through inducing oxidative stress, inhibiting MMP-9 expression and rebalancing M1/M2 tumor-associated macrophages phenotype in a mouse model of colon cancer
- (2020) Ning Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal
- (2019) Mingen Liu et al. NATURE IMMUNOLOGY
- Role of Extracellular Vesicles (EVs) in Cell Stress Response and Resistance to Cancer Therapy
- (2019) Clodagh O’Neill et al. Cancers
- The Notch signal mediates macrophage polarization by regulating miR-125a/miR-99b expression
- (2019) Qian Li et al. Artificial Cells Nanomedicine and Biotechnology
- Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
- (2019) Rongsheng Zhang et al. Cell Death & Disease
- Breast phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression which can be inhibited by CCR5 inhibition Therapy
- (2019) Hai Hu et al. CLINICAL CANCER RESEARCH
- One Clever Macrophage Checkpoint
- (2019) Alberto Mantovani et al. CLINICAL CANCER RESEARCH
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- Emerging Role of Glycosylation in the Polarization of Tumor-Associated Macrophages
- (2019) Natalia Rodrigues Mantuano et al. PHARMACOLOGICAL RESEARCH
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity
- (2019) Javier Mora et al. Cells
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling
- (2019) Yoko K. Takada et al. JOURNAL OF IMMUNOLOGY
- Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
- (2019) Hongcheng Yang et al. Cancer Medicine
- Ontogeny of Tumor-Associated Macrophages
- (2019) Marie Laviron et al. Frontiers in Immunology
- Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation
- (2019) Shahzad Nawaz Syed et al. Cells
- TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
- (2019) Harald Wajant et al. Frontiers in Cell and Developmental Biology
- Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
- (2019) Laura Fantuzzi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Macrophage activation by a substituted pyrimido[5,4-b]indole increases anti-cancer activity
- (2019) Joseph Hardie et al. PHARMACOLOGICAL RESEARCH
- CD47: role in the immune system and application to cancer therapy
- (2019) Seyed Mohammad Gheibi Hayat et al. CELLULAR ONCOLOGY
- The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
- (2019) Vanessa Barriga et al. Cancers
- LBA29Immune activation with a novel immune switch anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) in phase I/II first-in-human MATINS trial in patients with advanced solid tumours
- (2019) P Bono et al. ANNALS OF ONCOLOGY
- The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity
- (2019) Lixin Wang et al. Frontiers in Pharmacology
- Discovery of potent ureido tetrahydrocarbazole derivatives for cancer treatments through targeting tumor-associated macrophages
- (2019) Haixiang Pei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer
- (2019) Wei Li et al. Cell Death & Disease
- Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
- (2018) Xuyao Zhang et al. CARCINOGENESIS
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity
- (2018) Tianxiao Yang et al. Journal of Hematology & Oncology
- Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN
- (2018) Ya-Ling Hsu et al. MOLECULAR THERAPY
- Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization
- (2018) Mengyang Li et al. Cell Death & Disease
- Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
- (2018) Huseyin Atakan Ekiz et al. OncoImmunology
- Targeting Macrophages in Cancer: From Bench to Bedside
- (2018) Ashleigh R. Poh et al. Frontiers in Oncology
- ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
- (2018) Steven E. Kauder et al. PLoS One
- Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
- (2018) Julie G Grossman et al. OncoImmunology
- Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
- (2018) Shicheng Su et al. CELL
- Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530
- (2018) Silvia L. Locatelli et al. CLINICAL CANCER RESEARCH
- Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages
- (2018) Yong Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- M2b macrophage polarization and its roles in diseases
- (2018) Le-xun Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
- (2018) Asim Pervaiz et al. CELLULAR ONCOLOGY
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- Autophagy suppresses isoprenaline-induced M2 macrophage polarization via the ROS/ERK and mTOR signaling pathway
- (2017) Meihua Shan et al. FREE RADICAL BIOLOGY AND MEDICINE
- CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk
- (2017) Pinjia Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
- (2017) Jennifer L. Guerriero et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- Two-step enhanced cancer immunotherapy with engineeredSalmonella typhimuriumsecreting heterologous flagellin
- (2017) Jin Hai Zheng et al. Science Translational Medicine
- Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy
- (2017) Xiang Zheng et al. Oncotarget
- Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
- (2017) Géraldine Genard et al. Frontiers in Immunology
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma
- (2016) Hridayesh Prakash et al. CARCINOGENESIS
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- Chemotherapy and immunotherapy: mapping the road ahead
- (2016) Alistair M Cook et al. CURRENT OPINION IN IMMUNOLOGY
- Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of itsin vivosynergism with gemcitabine, in pancreatic adenocarcinoma mouse models
- (2016) María Virtudes Céspedes et al. Disease Models & Mechanisms
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects
- (2016) F. Piaggio et al. JOURNAL OF CONTROLLED RELEASE
- Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development
- (2016) Okito Hashimoto et al. JOURNAL OF PATHOLOGY
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
- (2016) Caroline Baer et al. NATURE CELL BIOLOGY
- Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
- (2016) Saeid Zanganeh et al. Nature Nanotechnology
- Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
- (2016) Yuval Shaked Nature Reviews Clinical Oncology
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
- (2016) Teresa E. Peterson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
- (2016) Catherine A. Evans et al. ACS Medicinal Chemistry Letters
- Macrophage PI3K Drives Pancreatic Ductal Adenocarcinoma Progression
- (2016) M. M. Kaneda et al. Cancer Discovery
- Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
- (2016) Manuela Liguori et al. Oncotarget
- Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts
- (2016) Giuseppina Comito et al. Oncotarget
- TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype
- (2016) Fan Zhang et al. Oncotarget
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
- (2016) Dror Alishekevitz et al. Cell Reports
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications
- (2016) Erika Vacchelli et al. OncoImmunology
- Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities
- (2016) Ana Teresa Pinto et al. Scientific Reports
- A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
- (2015) A. K. Nowak et al. ANNALS OF ONCOLOGY
- Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
- (2015) T. R. W. Tipton et al. BLOOD
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
- (2015) N. Gul et al. CANCER RESEARCH
- Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma
- (2015) Nengwang Yu et al. INTERNATIONAL JOURNAL OF CANCER
- FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis
- (2015) Bin-Zhi Qian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion
- (2015) Martin Franz Sprinzl et al. JOURNAL OF HEPATOLOGY
- Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages
- (2015) Yun Shi et al. JOURNAL OF IMMUNOLOGY
- Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization
- (2015) Jason H. Stafford et al. NEURO-ONCOLOGY
- Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
- (2015) William D. Tap et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
- (2015) C Raggi et al. ONCOGENE
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
- (2015) Li Yang et al. Oncotarget
- CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma
- (2014) Young Wha Koh et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
- (2014) David A. Smith et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Qing-Min Fan et al. CANCER LETTERS
- The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: Focus on macrophage polarization of THP-1 cells
- (2014) Xian-Feng Wang et al. CELLULAR IMMUNOLOGY
- Modes of action of TLR7 agonists in cancer therapy
- (2014) Sebastian Kobold et al. Immunotherapy
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophage PTEN Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses
- (2014) Emine Sahin et al. JOURNAL OF IMMUNOLOGY
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
- (2014) Xuesong Wu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
- (2014) A. J. Garcia et al. MOLECULAR AND CELLULAR BIOLOGY
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- The cellular and molecular origin of tumor-associated macrophages
- (2014) R. A. Franklin et al. SCIENCE
- Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
- (2014) C. M. Lovly et al. Cancer Discovery
- Regulation of Macrophage Polarization by RON Receptor Tyrosine Kinase Signaling
- (2014) Amitabha Chaudhuri Frontiers in Immunology
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Myeloid-Specific Expression of Ron Receptor Kinase Promotes Prostate Tumor Growth
- (2013) D. Gurusamy et al. CANCER RESEARCH
- Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
- (2013) I. Le Mercier et al. CANCER RESEARCH
- Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy
- (2013) S. Mok et al. CANCER RESEARCH
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages
- (2013) Amitabha Chaudhuri et al. IMMUNOLOGY AND CELL BIOLOGY
- Fcγ Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies
- (2013) Steven E. Justiniano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CXCR4-Targeted Therapy Inhibits VEGF Expression and Chondrosarcoma Angiogenesis and Metastasis
- (2013) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis
- (2013) Shu-Chi Wang et al. PLoS One
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Inhibition of Ron Kinase Blocks Conversion of Micrometastases to Overt Metastases by Boosting Antitumor Immunity
- (2013) H. Eyob et al. Cancer Discovery
- Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
- (2012) Zhengzhi Zou et al. Autophagy
- Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers
- (2012) Zhen Huang et al. BIOMATERIALS
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- Anti-tumour strategies aiming to target tumour-associated macrophages
- (2012) Xiaoqiang Tang et al. IMMUNOLOGY
- Low dose ionising radiation leads to a NF-κB dependent decreased secretion of active IL-1β by activated macrophages with a discontinuous dose-dependency
- (2012) Barbara Lödermann et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
- (2012) A. Arranz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
- (2012) H. Shime et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155
- (2012) Xing Cai et al. Journal of Molecular Cell Biology
- Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
- (2011) D. A. Hume et al. BLOOD
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase
- (2011) D. R. Sharda et al. JOURNAL OF IMMUNOLOGY
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- Tumour macrophages as potential targets of bisphosphonates
- (2011) Thea L Rogers et al. Journal of Translational Medicine
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions
- (2010) S. B. Coffelt et al. CANCER RESEARCH
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages
- (2010) Justin P. Edwards et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
- (2009) Marta Coscia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
- (2009) John F. DiPersio et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
- (2009) Carmen Cuevas et al. NATURAL PRODUCT REPORTS
- Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin
- (2009) Karel Otero et al. NATURE IMMUNOLOGY
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- (2008) Xiao-Dong Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
- Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome
- (2008) H. Lin et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started